20/20 GeneSystems Revenue and Competitors
Estimated Revenue & Valuation
- 20/20 GeneSystems's estimated annual revenue is currently $2.6M per year.
- 20/20 GeneSystems's estimated revenue per employee is $77,520
- 20/20 GeneSystems's total funding is $14.4M.
Employee Data
- 20/20 GeneSystems has 34 Employees.
- 20/20 GeneSystems grew their employee count by -8% last year.
20/20 GeneSystems's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Operating Office | Reveal Email/Phone |
2 | CLIA Medical Director | Reveal Email/Phone |
3 | President & CEO | Reveal Email/Phone |
4 | BioAnalytics | Reveal Email/Phone |
5 | Business Development, China | Reveal Email/Phone |
6 | Business Development, U.S | Reveal Email/Phone |
7 | General Supervisor | Reveal Email/Phone |
8 | Sales Representative | Reveal Email/Phone |
9 | National Business Development Manager | Reveal Email/Phone |
10 | Clinical Laboratory Technician | Reveal Email/Phone |
20/20 GeneSystems Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.9M | 77 | N/A | N/A | N/A |
#2 | $557.1M | 3901 | 5% | N/A | N/A |
#3 | $4M | 49 | -6% | N/A | N/A |
#4 | $3.8M | 46 | 7% | N/A | N/A |
#5 | $2.6M | 35 | N/A | N/A | N/A |
#6 | $21M | 187 | N/A | N/A | N/A |
#7 | $2.1M | 29 | -19% | N/A | N/A |
#8 | $279.6M | 1958 | N/A | N/A | N/A |
#9 | $67.1M | 526 | 5% | N/A | N/A |
#10 | $706.1M | 4945 | N/A | N/A | N/A |
What Is 20/20 GeneSystems?
20/20 GeneSystems (www.2020gene.com), based in Rockville, MD, was founded in May 2000 to co-develop the P-FILM technology with the National Cancer Institute. The privately held company maintains exclusive rights to this technology.
keywords:N/A$14.4M
Total Funding
34
Number of Employees
$2.6M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
20/20 GeneSystems News
20/20 GeneSystems BioVeris. General Dynamics Canada BioSentinel Pharmaceuticals Smiths Group BD Biosciences Immunocytometry Systems
... Forecast Key Players | Dias Orin, Epigenetics, Techlab, Positive Bioscience, Genextropy, M Genomics, 20/20 GeneSystems, AB SCIEX, A
20/20 GeneSystems, Inc., a Rockville, Maryland-based developer of tumor biomarker diagnostics via big-data healthcare analytics, raised $4.5m in new Series A equity funding. Backers included Ping An Ventures and several family offices and individual investors, many affiliated with the Keiretsu ...
Featured companies: 20/20 GeneSystems, Bellicum Pharmaceuticals, Cumbre Pharmaceuticals, Dara BioSciences, Enterprise Partners Venture Capital, Fermentas, International, Iasis Medical, New Leaf Venture Partners, Point Therapeutics, Power Medical Interventions, Rules-Based Medicine, Spinal Restor ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.9M | 34 | -3% | N/A |
#2 | $2.7M | 34 | 0% | N/A |
#3 | $15M | 34 | 0% | N/A |
#4 | $6M | 34 | -19% | N/A |
#5 | $7.3M | 34 | -13% | N/A |